| Dr Kimberly Gregory, MD | |
|
8700 Beverly Blvd, Los Angeles, CA 90048-1865 | |
| (310) 423-5420 | |
| (310) 423-0140 |
| Full Name | Dr Kimberly Gregory |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 8700 Beverly Blvd, Los Angeles, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033192356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | G68785 (California) | Secondary |
| 207V00000X | Obstetrics & Gynecology | G68785 (California) | Primary |
| Entity Name | Cedars-sinai Medical Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316984388 PECOS PAC ID: 0941106645 Enrollment ID: O20040202000464 |
News Archive
Treatment of hospital-related infections in the U.S. costs up to $11 billion a year and about half of those infections are related to medical devices implanted in patients. Until now, efforts to control drug-resistant biofilms on such devices have been largely unsuccessful.
A patient health and safety survey of 190 American hospitals from coast to coast compiled by registered nurses in eight different states finds that a disturbing number of our nation's healthcare facilities are not prepared for the coming H1N1/swine flu pandemic, according to results released today by the California Nurses Association/National Nurses Organizing Committee.
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing Teva's New Drug Application (NDA) for beclomethasone dipropionate hydrofluoroalkane (BDP Nasal HFA), a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).
A study led by researchers at the National Institutes of Health has made a surprising connection between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two disorders of the nervous system, and the genetic mutation normally understood to cause Huntington's disease.
Another difference between females and males appears to be a key mechanism in how they become hypertensive, scientists say, and consequently which antihypertensives should be most effective for them.
› Verified 8 days ago
| Entity Name | Cedars-sinai Medical Center Pharmacy #3 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639172372 PECOS PAC ID: 0446169114 Enrollment ID: O20040204000886 |
News Archive
Treatment of hospital-related infections in the U.S. costs up to $11 billion a year and about half of those infections are related to medical devices implanted in patients. Until now, efforts to control drug-resistant biofilms on such devices have been largely unsuccessful.
A patient health and safety survey of 190 American hospitals from coast to coast compiled by registered nurses in eight different states finds that a disturbing number of our nation's healthcare facilities are not prepared for the coming H1N1/swine flu pandemic, according to results released today by the California Nurses Association/National Nurses Organizing Committee.
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing Teva's New Drug Application (NDA) for beclomethasone dipropionate hydrofluoroalkane (BDP Nasal HFA), a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).
A study led by researchers at the National Institutes of Health has made a surprising connection between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two disorders of the nervous system, and the genetic mutation normally understood to cause Huntington's disease.
Another difference between females and males appears to be a key mechanism in how they become hypertensive, scientists say, and consequently which antihypertensives should be most effective for them.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Gregory, MD Po Box 512717, Los Angeles, CA 90051-0717 Ph: (310) 423-5420 | Dr Kimberly Gregory, MD 8700 Beverly Blvd, Los Angeles, CA 90048-1865 Ph: (310) 423-5420 |
News Archive
Treatment of hospital-related infections in the U.S. costs up to $11 billion a year and about half of those infections are related to medical devices implanted in patients. Until now, efforts to control drug-resistant biofilms on such devices have been largely unsuccessful.
A patient health and safety survey of 190 American hospitals from coast to coast compiled by registered nurses in eight different states finds that a disturbing number of our nation's healthcare facilities are not prepared for the coming H1N1/swine flu pandemic, according to results released today by the California Nurses Association/National Nurses Organizing Committee.
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing Teva's New Drug Application (NDA) for beclomethasone dipropionate hydrofluoroalkane (BDP Nasal HFA), a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).
A study led by researchers at the National Institutes of Health has made a surprising connection between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two disorders of the nervous system, and the genetic mutation normally understood to cause Huntington's disease.
Another difference between females and males appears to be a key mechanism in how they become hypertensive, scientists say, and consequently which antihypertensives should be most effective for them.
› Verified 8 days ago
Christine Carter Sterling, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1200 N State St, Inpt Tower C3f107, Los Angeles, CA 90033 Phone: 323-409-8847 | |
Dr. Sonya Fabricant, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2051 Marengo St, Los Angeles, CA 90033 Phone: 323-409-8848 | |
Ingrid Rodi, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Medical Plz, 202, Los Angeles, CA 90095 Phone: 310-794-7274 | |
Mary Gatter, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 400 W 30th St, Los Angeles, CA 90007 Phone: 213-284-3211 | |
Dr. James Allan Mcgregor, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1240 N Mission Rd, Room 5k40, Los Angeles, CA 90033 Phone: 323-221-3270 Fax: 323-226-2710 | |
Dr. Crystal Lynn Adams, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2020 Zonal Avenue, Ird 220, Los Angeles, CA 90033 Phone: 323-226-3423 Fax: 323-226-3509 | |
Dr. Vladimir Nossov, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Department Of Ob/gyn Ucla Medical Center, 10833 Leconte Avenue, Los Angeles, CA 90095 Phone: 310-206-6766 |